• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病学的未来发展:无需持悲观态度。

The future developments in hepatology: no need for a jaundiced view.

作者信息

Elsharkawy Ahmed Mohamed, Hudson Mark

机构信息

Liver Unit, University Hospitals Birmingham, Birmingham, UK.

Liver Unit, Freeman Hospital, Newcastle upon Tyne, UK.

出版信息

Frontline Gastroenterol. 2012 Jul;3(Suppl 1):i47-i52. doi: 10.1136/flgastro-2012-100153. Epub 2012 May 31.

DOI:10.1136/flgastro-2012-100153
PMID:28839693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5551950/
Abstract

There have been major advances in the diagnosis and management of all forms of liver disease since the British Society of Gastroenterology first came into existence 75 years ago. In this review some of the exciting developments that are likely to enter into routine clinical practice over the next 5 years are highlighted. It is suggested that some critical changes need to take place in UK hepatology over the next decade to ensure that the management of liver disease in this country continues to be among the best in the world.

摘要

自英国胃肠病学会75年前成立以来,各种肝病的诊断和管理都取得了重大进展。在这篇综述中,重点介绍了一些可能在未来5年进入常规临床实践的令人兴奋的进展。有人认为,在未来十年,英国肝病学需要发生一些关键变化,以确保该国肝病的管理继续位居世界前列。

相似文献

1
The future developments in hepatology: no need for a jaundiced view.肝病学的未来发展:无需持悲观态度。
Frontline Gastroenterol. 2012 Jul;3(Suppl 1):i47-i52. doi: 10.1136/flgastro-2012-100153. Epub 2012 May 31.
2
Workforce in hepatology: Update and a critical need for more information.肝科学领域的劳动力:更新和对更多信息的迫切需求。
Hepatology. 2017 Jan;65(1):336-340. doi: 10.1002/hep.28810. Epub 2016 Oct 25.
3
Chapter 3. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Recent Years.第3章. 近年来的欧洲儿科胃肠病学、肝病学和营养学会
J Pediatr Gastroenterol Nutr. 2018 Apr;66 Suppl 1:S29-S43. doi: 10.1097/MPG.0000000000001913.
4
Hepatology training in the UK.英国的肝病学培训。
Frontline Gastroenterol. 2012 Jan;3(1):52-56. doi: 10.1136/flgastro-2011-100028. Epub 2011 Nov 11.
5
Hepatology after Hepatitis C.丙型肝炎后的肝病学
Dig Dis. 2016;34(5):603-6. doi: 10.1159/000445276. Epub 2016 Jun 22.
6
Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.婴儿胆汁淤积性黄疸评估指南:北美小儿胃肠病、肝病和营养学会与欧洲小儿胃肠病、肝病和营养学会联合推荐
J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):154-168. doi: 10.1097/MPG.0000000000001334.
7
An overview of the challenges and key initiatives in hepatology practice in the UK in 2022: a cautionary tale, but reasons for optimism - British Association for the Study of the Liver (BASL) Annual Meeting 2022 Conference Report.2022 年英国肝脏病学实践中的挑战和关键举措概述:一个警示故事,但有理由保持乐观——英国肝脏研究学会(BASL)2022 年年会会议报告。
Clin Med (Lond). 2023 Jan;23(1):73-75. doi: 10.7861/clinmed.2022-0443.
8
Cell-free DNA testing: future applications in gastroenterology and hepatology.游离DNA检测:在胃肠病学和肝病学中的未来应用
Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841896. doi: 10.1177/1756284819841896. eCollection 2019.
9
Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN).小儿胃食管反流临床实践指南:北美小儿胃肠病学、肝病学和营养学学会(NASPGHAN)和欧洲小儿胃肠病学、肝病学和营养学学会(ESPGHAN)的联合建议。
J Pediatr Gastroenterol Nutr. 2009 Oct;49(4):498-547. doi: 10.1097/MPG.0b013e3181b7f563.
10
Development of gastroenterology and hepatology in Iran: Part II- advances in research and therapeutic modalities.伊朗胃肠病学和肝病学的发展:第二部分——研究与治疗方式的进展
Arch Iran Med. 2009 Sep;12(5):516-25.

本文引用的文献

1
Management of HCC.肝癌的治疗。
J Hepatol. 2012;56 Suppl 1:S75-87. doi: 10.1016/S0168-8278(12)60009-9.
2
Management of critically-ill cirrhotic patients.危重症肝硬化患者的管理。
J Hepatol. 2012;56 Suppl 1:S13-24. doi: 10.1016/S0168-8278(12)60003-8.
3
Generic immunosuppression in solid organ transplantation: a Canadian perspective.实体器官移植中的通用免疫抑制:加拿大视角。
Transplantation. 2012 Apr 15;93(7):657-65. doi: 10.1097/TP.0b013e3182445e9d.
4
Preliminary study of two antiviral agents for hepatitis C genotype 1.慢性丙型肝炎病毒感染的抗病毒治疗进展
N Engl J Med. 2012 Jan 19;366(3):216-24. doi: 10.1056/NEJMoa1104430.
5
Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury.心脏死亡后捐献肝脏移植受者发生急性肾损伤的频率增加。
Am J Transplant. 2012 Apr;12(4):965-75. doi: 10.1111/j.1600-6143.2011.03894.x. Epub 2012 Jan 6.
6
Get active.
J Hepatol. 2012 Jan;56(1):5-6. doi: 10.1016/j.jhep.2011.09.005.
7
Belatacept: from rational design to clinical application.贝他西普:从合理设计到临床应用。
Transpl Int. 2012 Feb;25(2):139-50. doi: 10.1111/j.1432-2277.2011.01386.x. Epub 2011 Dec 7.
8
Hepatitis C virus: current concepts and future challenges.丙型肝炎病毒:当前概念与未来挑战。
QJM. 2012 Jan;105(1):29-32. doi: 10.1093/qjmed/hcr231. Epub 2011 Nov 28.
9
Treatment of non-genotype 1 hepatitis C virus patients.非1型丙型肝炎病毒患者的治疗。
Curr Gastroenterol Rep. 2012 Feb;14(1):87-93. doi: 10.1007/s11894-011-0235-3.
10
Interferon free hepatitis C treatment regimens: the beginning of another era.不含干扰素的丙型肝炎治疗方案:另一个时代的开端。
Curr Gastroenterol Rep. 2012 Feb;14(1):74-7. doi: 10.1007/s11894-011-0229-1.